{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:44:20Z","timestamp":1771461860848,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1997,12,1]],"date-time":"1997-12-01T00:00:00Z","timestamp":880934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[1997,12]]},"DOI":"10.1016\/s1071-9164(97)90029-4","type":"journal-article","created":{"date-parts":[[2004,6,22]],"date-time":"2004-06-22T17:29:16Z","timestamp":1087925356000},"page":"295-302","source":"Crossref","is-referenced-by-count":13,"title":["Angiotensin-converting enzyme inhibitors in heart failure: Physicians' prescribing behavior"],"prefix":"10.1016","volume":"3","author":[{"given":"A.","family":"Ferreira","sequence":"first","affiliation":[]},{"given":"P.","family":"Bettencourt","sequence":"additional","affiliation":[]},{"given":"M.","family":"Cortez","sequence":"additional","affiliation":[]},{"given":"J.P.","family":"Ara\u00fajo","sequence":"additional","affiliation":[]},{"given":"M.","family":"Cerqueira-Gomes","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1071-9164(97)90029-4_BIB1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0735-1097(83)80316-7","article-title":"A placebo-controlled trial of refractory chronic congestive heart failure","volume":"2","year":"1983","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM198610023151402","article-title":"Comparison of captopril and enalapril in patients with severe chronic heart failure","volume":"315","author":"Packer","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB3","doi-asserted-by":"crossref","first-page":"67A","DOI":"10.1016\/S0002-9149(88)80088-2","article-title":"Tolerability of enalapril in congestive heart failure","volume":"62","author":"Kjekshus","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB4","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival of patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"SOLVD Investigators","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM199108013250502","article-title":"A comparison of enalapril with hydralazine-isosorbide in the treatment of chronic congestive heart failure","volume":"325","author":"Cohn","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0735-1097(94)90426-X","article-title":"Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction","volume":"23","author":"Rogers","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB8","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archinte.154.10.1143","article-title":"Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure","volume":"154","author":"Paul","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB9","first-page":"91","article-title":"The cost effectiveness of enalapril in the treatment of chronic heart failure","volume":"6","author":"Hart","year":"1993","journal-title":"Br J Med Econ"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00019501-199504000-00008","article-title":"ACE inhibitors and healthcare economics","volume":"6","author":"Davie","year":"1995","journal-title":"Coronary Artery Dis"},{"issue":"suppl. A","key":"10.1016\/S1071-9164(97)90029-4_BIB11","first-page":"I4A","article-title":"Natural history and patterns of current practice in heart failure","volume":"22","author":"Bourassa","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB12","first-page":"S107","article-title":"Economic impact of heart failure in the United States: time for a different approach","volume":"13","author":"O'Connell","year":"1994","journal-title":"J Heart Lung Transplant"},{"issue":"suppl. A","key":"10.1016\/S1071-9164(97)90029-4_BIB13","doi-asserted-by":"crossref","first-page":"198A","DOI":"10.1016\/0735-1097(93)90491-I","article-title":"Perspective of the pharmaceutical industry on the development of new drugs for heart failure","volume":"22","author":"Rajfer","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB14","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0002-9149(97)89177-1","article-title":"Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals","volume":"77","author":"Philbin","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0021-9681(85)90115-8","article-title":"An analysis of physicians' reasons for prescribing longterm digitalis therapy in outpatients","volume":"38","author":"Carlson","year":"1985","journal-title":"J Chron Dis"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/clpt.1993.100","article-title":"The need for a sodium retention score in clinical trials of heart failure","volume":"54","author":"Cody","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB17","year":"1993","journal-title":"SPSS for Windows users' guide SPSS"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB18","first-page":"395","article-title":"Epidemiologic aspects of congestive heart failure: retrospective analysis of 2561 hospital admissions","volume":"15","author":"Ferreira","year":"1996","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB20","first-page":"1115","article-title":"Effects of lisinopril and transdermal glyceril trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction","volume":"343","author":"GISSI-3","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","article-title":"A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction","volume":"345","author":"ISIS-4","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199501123320203","article-title":"The effect of the angiotensin-converting enzyme inhibitor zofenopril on mortality after anterior myocardial infarction","volume":"332","author":"Ambrosioni","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB23","first-page":"617","article-title":"Pharmacological therapy of acute myocardial infarction: from large trials to clinical practice in a central hospital","volume":"15","author":"Fernando","year":"1996","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.303.6794.81","article-title":"Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria","volume":"303","author":"Mathiesen","year":"1991","journal-title":"Br Med J"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB25","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin converting enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.271.4.275","article-title":"Effect of captopril on progression to clinical proteinuria in patients with IDDM and microalbuminuria","volume":"271","author":"Viberti","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-118-8-199304150-00001","article-title":"Long-term stabilizing effect of angiotensin converting enzyme inhibition on plasma creatinine and proteinuria in normotensive type II diabetic patients","volume":"118","author":"Ravid","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/archinte.149.3.669","article-title":"Renal hemodynamic consequences of angiotensin-converting enzyme inhibition in congestive heart failure","volume":"149","author":"Suki","year":"1989","journal-title":"Arch Intern Med"},{"issue":"suppl. 8","key":"10.1016\/S1071-9164(97)90029-4_BIB29","first-page":"1","article-title":"Differences between cardiologists and heart failure specialists in the management of congestive heart failure","volume":"92","author":"Shah","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB30","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system","volume":"93","author":"Weber","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB31","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/0002-9149(93)90238-8","article-title":"Aldosterone and antialdosterone therapy in congestive heart failure","volume":"71","author":"Weber","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.0954-6820.1986.tb18112.x","article-title":"Intracellular electrolytes in cardiac failure","volume":"707","author":"Wester","year":"1986","journal-title":"Acta Med Scand"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0002-8703(92)90633-7","article-title":"Magnesium deficiency and sudden death","volume":"124","author":"Eisenberg","year":"1992","journal-title":"Am Heart J"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB34","first-page":"I","article-title":"The effect of a mineralcorticoid antagonist on myocardial mIBG uptake in congestive heart failure","volume":"88","author":"Barr","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/j.1552-4604.1993.tb03901.x","article-title":"Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors","volume":"33","author":"Borghi","year":"1993","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB36","first-page":"I","article-title":"Progression of left ventricular dysfunction during enalapril therapy: relation with neuro-hormonal reactivation","volume":"88","author":"Pouleur","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/S1071-9164(97)90029-4_BIB37","first-page":"I","article-title":"The randomized angiotensin receptor antagonist-ACE inhibitor study (RAAS): pilot study","volume":"94","author":"Pitt","year":"1996","journal-title":"Circulation"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916497900294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916497900294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T18:13:37Z","timestamp":1705169617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916497900294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,12]]}},"alternative-id":["S1071916497900294"],"URL":"https:\/\/doi.org\/10.1016\/s1071-9164(97)90029-4","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[1997,12]]}}}